Skip to main navigation Skip to search Skip to main content

Apixaban versus warfarin in patients with atrial fibrillation

  • Christopher Granger
  • , John Alexander
  • , John McMurray
  • , Renato Lopes
  • , Elaine Hylek
  • , Michael Hanna
  • , Hussein Al-Khalidi
  • , Jack Ansell
  • , Dan Atar
  • , Alvaro Avezum
  • , M Bahit
  • , Rafael Diaz
  • , Donald Easton
  • , Justin Ezekowitz
  • , Greg Flaker
  • , David Garcia
  • , Margarida Geraldes
  • , Bernard Gersh
  • , Sergey Golitsyn
  • , Shinya Goto
  • Antonio Hermosillo, Stefan Hohnloser, John Horowitz, Puneet Mohan, Petr Jansky, Basil Lewis, Jose Lopez-Sendon, Prem Pais, Alexander Parkhomenko, Freek Verheugt, Jun Zhu, Lars Wallentin, M Vico, I Mackinnon, D Vogel, A. Gabito, A Cassettari, C Zaidman, O Montana, A. Hrabar, H Jure, H Lastiri, C. Poy, A Caccavo, C Cuneo, H Colombo, F Rolandi, A Hershson, M Garrido, A Sanchez, M L Bruno, D Piskorz, J Cuadrado, E Hasbani, J Serra, L Cartasegna, P Schygiel, C Muratore, J Marino, M I Sosa Liprandi, R. A. Guerrero, H Ramos, D Mercado, L Guzmon, C Beneitez, J Estepo, R. Torrijos, E Retyk, N Vita, H Luciardi, M Casey, S Orlando, M B Labarta, D Santos, J Amerena, P Purnell, J Horowitz, H Salem, A Lui, L Zimmet, S Roger, Fred De Looze, R Lehman, B Jackson, D Ashby, W Heddle

Research output: Contribution to journalArticlepeer-review

8298 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Apixaban versus warfarin in patients with atrial fibrillation'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science